Halozyme Therapeutics
Trade Halozyme Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
As of today, Halozyme Therapeutics(HALO) shares are valued at $71.60. The company's market cap stands at 8.49B, with a P/E ratio of 25.11.
On 2026-06-04, Halozyme Therapeutics(HALO) stock traded between a low of $69.00 and a high of $72.09. Shares are currently priced at $71.60, which is +3.8% above the low and -0.7% below the high.
Halozyme Therapeutics(HALO) shares are trading with a volume of 2.2M, against a daily average of 1.78M.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $82.22 and a 52-week low of $51.06.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $82.22 and a 52-week low of $51.06.
HALO News
Recently, partner company argenx reported positive clinical data for a therapy using Halozyme Therapeutics’ ENHANZE drug delivery technology, alongside an analy...
Analyst ratings
64%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.